NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
Raquel Nunes
MedStar Washington Hospital Center - Washington / United States
Others
AD Scientific Index ID: 4615792
-
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Raquel Nunes's MOST POPULAR ARTICLES
1-)
PD-L2 is a second ligand for PD-1 and inhibits T cell activationY Latchman, CR Wood, T Chernova, D Chaudhary, M Borde, I Chernova, ...Nature immunology 2 (3), 261-268, 200132402001
2-)
Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II trial with clinical outcomes, analysis of serum tumor …HJ Burstein, LN Harris, PK Marcom, R Lambert-Falls, K Havlin, ...Journal of clinical oncology 21 (15), 2889-2895, 20034232003
3-)
Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot …HJ Burstein, LN Harris, R Gelman, SC Lester, RA Nunes, CM Kaelin, ...Journal of Clinical Oncology 21 (1), 46-53, 20033572003
4-)
The HER2 extracellular domain as a prognostic and predictive factor in breast cancerRA Nunes, LN HarrisClinical breast cancer 3 (2), 125-135, 20021372002
5-)
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt studyF Lynce, A Barac, X Geng, C Dang, AF Yu, KL Smith, C Gallagher, ...Breast cancer research and treatment 175, 595-603, 20191322019
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept